chr16-173300-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 6P and 2B. PM1PM2PP3_ModerateBP6_Moderate
The NM_000517.6(HBA2):c.271A>G(p.Lys91Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K91N) has been classified as Likely benign.
Frequency
Consequence
NM_000517.6 missense
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia spectrumInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- erythrocytosis, familial, 7Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hemoglobin M diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hb Bart's hydrops fetalisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin H diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Heinz body anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- methemoglobinemia, alpha typeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000517.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HBA2 | NM_000517.6 | MANE Select | c.271A>G | p.Lys91Glu | missense | Exon 2 of 3 | NP_000508.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HBA2 | ENST00000251595.11 | TSL:1 MANE Select | c.271A>G | p.Lys91Glu | missense | Exon 2 of 3 | ENSP00000251595.6 | ||
| HBA2 | ENST00000484216.1 | TSL:1 | c.238A>G | p.Lys80Glu | missense | Exon 2 of 2 | ENSP00000495899.1 | ||
| HBA2 | ENST00000482565.1 | TSL:1 | n.407A>G | non_coding_transcript_exon | Exon 1 of 2 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not provided Benign:1
The Hb Sudbury variant (HBA2: c.271A>G; p.Lys91Glu, also known as Lys90Glu when numbered from the mature protein, rs63750093, HbVar ID: 2637) has been described as a stable hemoglobin variant (see HbVar link). This variant is absent from the Genome Aggregation Database. The lysine at codon 91 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.616). Other amino acid substitutions at this codon (Gln, Arg, Met, Asn) have been reported as stable hemoglobin variants (see HbVar). Based on available information, this variant is considered to be likely benign. References: Link to HbVar: https://globin.bx.psu.edu/hbvar/menu.html
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at